Back to search

Estrogens in the Treatment of Prostate Cancer

Data up to Jan 2025

Published1995
Citations190
References92
Clinical Trials (1)

Total Citations Per Year

Abstract

References (92)

Campbell's urology

1986 • 3,494 citations

Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

1941 • 3,235 citations

STUDIES ON PROSTATIC CANCER

1941 • 1,498 citations

A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma

1989 • 1,494 citations

Cancer statistics, 1994

1994 • 1,345 citations

The veterans administration cooperative urological research group's studies of cancer of the prostate

1973 • 607 citations

Megestrol Acetate for the Prevention of Hot Flashes

1994 • 501 citations

ENDOCRINE CONTROL OF PROSTATIC CARCINOMA

1950 • 377 citations

Hormone Therapy for Prostate Cancer: Results of the Veterans Administration Cooperative Urological Research Group Studies

1989 • 304 citations

Estrogen treatment for cancer of the prostate.Early results with 3 doses of diethylstilbestrol and placebo

1970 • 246 citations

Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure

1986 • 220 citations

Carcinoma of the Prostate: Treatment Comparisons

1967 • 209 citations

Estramustine and Vinblastine: Use of Prostate Specific Antigen as a Clinical Trial End Point for Hormone Refractory Prostatic Cancer

1992 • 206 citations

Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma

1989 • 182 citations

Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic Cancer

1973 • 167 citations

Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic Carcinoma

1971 • 164 citations

Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate

1970 • 154 citations

Studies on Prostatic Cancer. III. The Effects of Fever, of Desoxycorticosterone and of Estrogen on Clinical Patients with Metastatic Carcinoma of the Prostate ,

1941 • 153 citations

TREATMENT OF URAEMIC BLEEDING WITH CONJUGATED OESTROGEN

1984 • 118 citations

Clinical Study of Leuprolide Depot Formulation in the Treatment of Advanced Prostate Cancer

1990 • 117 citations

Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)

1977 • 117 citations

Prostatic carcinoma; a follow-up on 795 patients treated prior to the endocrine era and a comparison of survival rates between these and patients treated by endocrine therapy.

1946 • 115 citations

Carcinoma of the prostate.

1956 • 115 citations

Alcman's Partheneion: Legend and Choral Ceremony

1994 • 97 citations

Cardiovascular Complications in the Treatment of Prostatic Carcinoma

1981 • 92 citations

Treatment of Radiation or Cyclophosphamide Induced Hemorrhagic Cystitis using Conjugated Estrogen

1990 • 78 citations

Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.

1988 • 77 citations

Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.

1986 • 74 citations

Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the Prostate

1981 • 71 citations

Treatment of advanced cancer of prostate with megestrol acetate

1978 • 70 citations

Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure

1990 • 64 citations

Effectiveness of Castration Versus Intravenous Estrogen Therapy in Producing Rapid Endocrine Control of Metastatic Cancer of the Prostate

1985 • 63 citations

Estrogen Dosage and Suppression of Testosterone Levels in Patients with Prostatic Carcinoma

1973 • 62 citations

Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.

1980 • 62 citations

Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone

1992 • 62 citations

A Comparison of Estramustine Phosphate Versus Cis-platinum Alone Versus Estramustine Phosphate Plus Cis-platinum in Patients with Advanced Hormone Refractory Prostate Cancer Who Had Had Extensive Irradiation to the Pelvis or Lumbosacral Area

1983 • 61 citations

Medical Castration of Males with Megestrol Acetate and Small Doses of Diethylstilbestrol*

1981 • 56 citations

Prostatic Carcinoma: Treatment of Advanced Cases with Intravenous Diethylstilbestrol Diphosphate

1955 • 55 citations

Sexual Function in Prostatic Cancer Patients Treated with Radiotherapy, Orchiectomy or Oestrogens

1984 • 52 citations

Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study.

1990 • 50 citations

Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate

1987 • 48 citations

Effect of Parenteral Oestrogen on the Coagulation System in Patients with Prostatic Carcinoma

1990 • 46 citations

The Combination of Cyproterone Acetate and Low Dose Diethylstilbestrol in the Treatment of Advanced Prostatic Carcinoma

1988 • 45 citations

Immediate Estrogen or Estramustine Phosphate Therapy Versus Deferred Endocrine Treatment in Nonmetastatic Prostate Cancer: A Randomized Multicenter Study With 15 Years of Followup

1995 • 40 citations

A Comparison of a Powerful Luteinizing Hormone Releasing Hormone Analogue Agonist and Estrogen in the Treatment of Advanced Prostatic Cancer

1984 • 39 citations

Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate

1976 • 38 citations

Comparison of various hormonal therapies for prostatic carcinoma.

1983 • 32 citations

VACURG studies of conservative treatment.

1980 • 32 citations

EFFECTS OF SYNTHETIC ORAL OESTROGENS IN NORMAL MEN AND PATIENTS WITH PROSTATIC CARCINOMA: LACK OF GONADOTROPHIN SUPPRESSION BY CHLOROTRIANISENE

1973 • 30 citations

Cardiovascular and all‐cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population

1991 • 30 citations

Primary Orchiectomy Versus Estrogen Therapy in Advanced Prostatic Cancer—A Randomized Study: Results After 7 to 10 Years of Followup

1991 • 30 citations

Plasma testosterone in patients receiving diethylstilbestrol

1978 • 29 citations

Comparison of Primary Orchiectomy with Oestrogen Therapy in Advanced Prostatic Cancer; A 2‐Year Follow‐up Report of a National, Prospective Prostatic Cancer Study

1986 • 29 citations

A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer

1985 • 28 citations

High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens.

1973 • 28 citations

The Diagnosis of Oestrogen Escape and the Role of Secondary Orchiectomy in Prostatic Cancer

1980 • 27 citations

A cooperative group study of prostatic cancer: stilbestrol versus placebo in advanced progressive disease.

1962 • 27 citations

Single Drug Polyestradiol Phosphate Therapy in Pro static Cancer

1988 • 24 citations

Preliminary Report on the Clinical Use of Tace (Chlorotrianisene) in Treatment of Prostatic Carcinoma

1951 • 24 citations

Control of Massive Hematuria in Idiopathic Hemorrhagic Cystitis after Administration of Conjugated Estrogen

1992 • 23 citations

EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.

1988 • 23 citations

Comparison of a Long-Acting LHRH Agonist and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Carcinoma

1994 • 20 citations

High‐dose Medroxyprogesterone Acetate versus Estramustine in Therapy‐resistant Prostatic Cancer: A Randomised Study

1991 • 20 citations

Estrogen treatment postpones the castration‐induced dedifferentiation of dunning R3327‐PAP prostatic adenocarcinoma

1994 • 20 citations

High Dose Polyoestradiol Phosphate with and without Acetosalicylic Acid versus Orchiectomy in the Treatment of Prostatic Cancer

1989 • 17 citations

Testicular Endocrine Function after Withdrawal of Oestrogen Treatment in Patients with Carcinoma of the Prostate

1983 • 16 citations

Stilphostrol therapy in 100 cases of prostatic carcinoma.

1969 • 16 citations

Do we have a rational treatment plan for stage D-1 carcinoma of the prostate?

1990 • 15 citations

Orchiectomy versus Oestrogen in the Treatment of Advanced Prostatic Cancer

1991 • 15 citations

Oestrogen Dosage in Prostatic Cancer: the Threshold Effect?

1989 • 15 citations

Plasma Hormone Levels in Patients with Prostatic Carcinoma Treated with Diethylstilboestrol and Estramustine

1985 • 15 citations

Hormonal Effects of Cessation of Estrogen Treatment for Prostatic Carcinoma

1987 • 15 citations

Effects of Orchiectomy and Polyestradiol Phosphate Therapy on Serum Lipoprotein Lipids and Glucose Tolerance in Prostatic Cancer Patients

1990 • 15 citations

Patients at High Risk of Cardiovascular Complications in Oestrogen Treatment of Prostatic Cancer

1989 • 14 citations

Primary therapy of metastatic prostate carcinoma with depot gonadotropin-releasing hormone analogue goserelin versus estramustine phosphate

1994 • 14 citations

Treatment Preferences of Urologists in Great Britain and Ireland in the Management of Prostate Cancer

1993 • 13 citations

Oestrogen in the Treatment of Prostatic Carcinoma

1989 • 12 citations

Relapse on endocrine treatment in patients with stage d2 prostate cancer

1993 • 12 citations

Comparison of Primary Orchiectomy and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Cancer

1990 • 11 citations

The Effects of Chlorotrianisene (Tace) on Kinetics of 3H-testosterone Metabolism in Patients with Carcinoma of the Prostate

1982 • 11 citations

Tace in the Treatment of Carcinoma of the Prostate: An 80-month Survey

1958 • 10 citations

Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.

1980 • 10 citations

Long-Term Effects of Endocrine Treatment on Serum Pituitary Hormones in Advanced Prostatic Carcinoma Patients

1981 • 10 citations

Experience in advanced prostatic cancer: Orchiectomy and flutamide versus orchiectomy and estramustine phosphate

1994 • 10 citations

Androgens during different modes of endocrine treatment of prostatic cancer

1989 • 10 citations

The choice of estrogen preparations in the treatment of prostatic cancer.

1975 • 9 citations

ORAL STILBCESTROL DIPHOSPHATE (“HONVAN”) IN THE TREATMENT OF PROSTATIC CARCINOMA: A CLINICAL TRIAL

1967 • 7 citations

Oestrogen therapy in prostatic cancer.

1980 • 6 citations

Some Effects of Treatment with Ethinyl Oestradiol with or Without Polyoestradiol Phosphate in Patients with Prostatic Carcinoma

1986 • 6 citations

Oestrogens reconsidered

1995 • 5 citations

EORTC Genitourinary Group Monograph 4—Management of Advanced Cancer of Prostate and Bladder

1989 • 2 citations

Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.

1980 • 2 citations

Cited By (0)

Loading...
Estrogens in the Treatment of Prostate Cancer (1995) – The Journal of Urology | Metascience Observatory Explorer